The 2 a.m. Question
Nobody searches for "testicular cancer."
What a 24-year-old actually types into his phone at 2 a.m. is "left testicle pain causes." Or "pea sized lump on testicle." He's been lying awake for an hour, running his thumb over the thing he felt in the shower, deciding whether it's real.
Our whole job at the Testicular Cancer Foundation is that moment. Testicular cancer is the most common cancer in young men, and caught early it's one of the most survivable cancers there is. Everything we publish exists for the window between the lump and the appointment.
In 2026 that window looks different. He isn't getting ten blue links anymore. More and more, he's getting an answer, written by AI, assembled from whatever sources the AI decides to trust.
We just pulled the data on what that shift means for us.
1.37 million answers in 53 days
Google recently began reporting how often a site's content shows up inside its AI-generated answers, the AI Overviews that now sit at the top of the results page. We exported our numbers the week the report went live.
Between May 18 and July 9, content from testicularcancer.org appeared in AI answers 1,368,627 times.
Those aren't visits to our website. They're moments when someone asked Google's AI about testicular health and the answer was built on our pages: symptom guides, self-exam instructions, treatment resources shaped by survivors who have actually been through it.
The trend is steeper than the total. In mid-May we appeared in about 16,000 AI answers a day. By early July it was more than 35,000, climbing every week. July 6 alone: 45,499.
What makes that hard to explain away is the backdrop. The Growth Memo's Search Signals Index tracks 2,600 companies, and it shows total AI mentions sitting flat at around 6 million a week since April. The pie isn't growing. We're being chosen more often out of the same pie.
Why the machine keeps picking us
When a search page was ten links, the winners were the big health aggregators, sites that collect and repackage everyone else's information at industrial scale. An AI answer doesn't need the middleman. It reaches past the aggregator to whoever actually knows the subject, the organization with first-hand knowledge and medically reviewed pages and a real point of view. Analysts have watched this same pattern lift the Mayo Clinic and Cleveland Clinic above the generic health portals.
We're a small foundation. We're never going to out-spend anyone, and we stopped trying a long time ago. What we can do is know this one disease better than anybody else who writes about it, down to answering the exact question a scared young man types, in the words he types it. That turns out to be what the machine rewards. We'll take it.
He's asking in Spanish
58% of our AI visibility comes from translated content. Spanish and Hindi lead, and the list keeps going through Arabic, German, Italian, Portuguese, Polish, French, Turkish, Dutch, and Chinese.
Only 30% of these appearances happened in the United States. Over those 53 days our content surfaced in AI answers in more than 190 countries. India accounts for more than 137,000 on its own. Germany, 108,000. Italy, 101,000. Mexico, 67,000. Then come the entries that make you sit back: Egypt, Syria, Saudi Arabia. In some of those places, saying the word "testicle" out loud to another person carries real stigma, and a question typed privately into a phone may be the only question a young man is ever willing to ask.
When we invested in translating our education library, the argument was simple: language should never be the reason a man ignores a warning sign. We did not predict that AI would become the way those translations reach people. But that's what's happening. A guy in Mexico City asking about a lump gets an answer built on our guidance, in Spanish, on his phone, in seconds. (80% of these impressions are mobile. Of course they are. This is not a question anyone researches at a desk at work.)
We've done awareness months and galas and campus events for years. None of it reaches like this.
Trust is the whole point
Pew Research reported in June that 44% of American adults now use ChatGPT, double what it was two years ago. The same survey found trust in AI falling while usage rises. People lean on the machine and doubt it at the same time.
That tension is where a foundation like ours earns its keep. An anonymous answer is only as trustworthy as the machine that wrote it. An answer that's built on, and cites, a foundation whose only mission is this disease carries its credibility with it. So our job in the AI era isn't just publishing good information anymore. It's being the named source inside the answer, so that a frightening moment turns into a doctor's visit instead of a shrug.
The sequence that saves a life is short. A symptom, a search, an answer he believes enough to act on. Then an ultrasound. Testicular cancer caught at stage one has a survival rate near 99%.
What we're doing next
An AI answer is not a doctor, and we won't pretend otherwise. Every piece of guidance we publish ends the same way: if you feel something, get checked.
But the data confirms something we've bet the mission on for years, which is that education scales. So we're auditing our most-cited guides to make sure every claim is current and medically reviewed. We're expanding the translated library that's already answering questions on five continents. And we're publishing these numbers openly, because we'd rather every health nonprofit learn from them than have them sit in a spreadsheet.
Somewhere in those 1.37 million answers is a man who found a lump, asked his phone, got a real answer, and made the appointment. He's why we do this. If you want more of those answers out in the world, in more languages, reaching more men in that 2 a.m. moment, support our work.
The lump doesn't wait for business hours. The answer shouldn't either.
Data: Google Search Console "Search Generative AI" performance report for testicularcancer.org, May 18 to July 9, 2026. Industry benchmarks: Growth Memo Search Signals Index (GIB #21, July 2026); Pew Research Center survey of 5,119 U.S. adults, June 2026.
